137 related articles for article (PubMed ID: 3117133)
21. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
22. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
[TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-2 receptor in hairy-cell leukemia: a reliable marker of disease.
Ambrosetti A; Nadali G; Vinante F; Ricetti MM; Todeschini G; Morosato L; de Sabata D; Bergamo Andreis IA; Chilosi M; Semenzato G
Int J Clin Lab Res; 1993; 23(1):34-7. PubMed ID: 8477089
[TBL] [Abstract][Full Text] [Related]
24. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
25. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
26. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
27. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
[TBL] [Abstract][Full Text] [Related]
28. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP
Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929
[TBL] [Abstract][Full Text] [Related]
29. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
30. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
[TBL] [Abstract][Full Text] [Related]
31. Induction of the interleukin-2 receptor (p55) by interferons.
Onji M; Yamaguchi S; Masumoto T; Akbar SM; Kajino K; Ohta Y
J Interferon Res; 1991 Aug; 11(4):237-41. PubMed ID: 1680935
[TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
33. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
34. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia.
Cimino G; Annino L; Giona F; Sgadari C; Di Gregorio AO; Cava MC; Cimino G; Mandelli F
Leukemia; 1991 Jul; 5(7):602-5. PubMed ID: 2072745
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia.
Gibson J; Gallagher K; Cameron K; Basten A; Gatenby P; Joshua D; Kronenberg H
Aust N Z J Med; 1988 Dec; 18(7):897-9. PubMed ID: 3074762
[No Abstract] [Full Text] [Related]
36. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease.
Yasuda N; Lai PK; Ip SH; Kung PC; Hinuma Y; Matsuoka M; Hattori T; Takatsuki K; Purtilo DT
Blood; 1988 Apr; 71(4):1021-6. PubMed ID: 2895675
[TBL] [Abstract][Full Text] [Related]
37. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
Griffiths SD; Cawley JC
Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
[TBL] [Abstract][Full Text] [Related]
38. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
Cordingley FT; Hoffbrand AV; Brenner MK
Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
Lauria F; Foà R; Raspadori D; Pileri S; Tassinari A; Buzzi M; Zaccaria A; Zinzani PL; Tura S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():176-8. PubMed ID: 2785426
[TBL] [Abstract][Full Text] [Related]
40. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
Teichmann JV; Sieber G; Ludwig WD; Ruehl H
J Interferon Res; 1988 Feb; 8(1):15-24. PubMed ID: 3259251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
